Undeclared Sibutramine Prompts Envy Me to Recall LaBri's Body Health Atomic Weight Loss Supplement

sibutramine is known to increase blood pressure and/or pulse rate in some patients and may be a significant risk for patients with Preexisting heart conditions

Undeclared Sibutramine Prompts Envy Me to Recall LaBri's Body Health Atomic Weight Loss Supplement
March 30, 2017

Envy Me is recalling LaBri's Body Health Atomic dietary supplement marketed for weight loss, sold in 60 capsule plastic bottles. The U.S. Food and Drug Administration (FDA) has analyzed samples of La Bri's Body Health Atomic and found it to contain the undeclared ingredient sibutramine.

Sibutramine is a controlled substance that was removed from the market in October 2010 for safety reasons. The product poses a threat to consumers because sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. Sibutramine may also interact, in life-threatening ways, with other medications a consumer may be taking.

The recall is being conducted to the consumer level and it includes all lot codes, manufacturing codes, and expiration dates.

Envy Me has not received any reports of illnesses to date in connection with this recall, however, the FDA reports one adverse event reported in June 2016.

The products were sold nationwide through internet sale and we began shipping this product in early 2015.

Consumers should stop using the product immediately and throw it away in accordance with your state and local ordinances for drug products or return the unused portion of product for a refund or replacement.

Consumers with any additional questions or concerns regarding this recall can contact our office at (361) 658-0241.